PubMed

Clinical effects of raloxifene hydrochloride in women.

Khovidhunkit W, Shoback DM.

Ann Intern Med. 1999 Mar 2;130(5):431-9. Review.PMID: 10068418 [PubMed - indexed for MEDLINE]Related articlesFree article

Cardiovascular effects of raloxifene hydrochloride.

Saitta A, Morabito N, Frisina N, Cucinotte D, Corrado F, D'Anna R, Altavilla D, Squadrito G, Minutoli L, Arcoraci V, Cancellieri F, Squadrito F.

Cardiovasc Drug Rev. 2001 Spring;19(1):57-74. Review.PMID: 11314601 [PubMed - indexed for MEDLINE]Related articles

Raloxifene: a selective estrogen receptor modulator.

Scott JA, Da Camara CC, Early JE.

Am Fam Physician. 1999 Sep 15;60(4):1131-9. Review.PMID: 10507743 [PubMed - indexed for MEDLINE]Related articles

Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women.

Delmas PD, Bjarnason NH, Mitlak BH, Ravoux AC, Shah AS, Huster WJ, Draper M, Christiansen C.

N Engl J Med. 1997 Dec 4;337(23):1641-7.PMID: 9385122 [PubMed - indexed for MEDLINE]Related articlesFree article

Prevention of osteoporosis and uterine effects in postmenopausal women taking raloxifene for 5 years.

Jolly EE, Bjarnason NH, Neven P, Plouffe L Jr, Johnston CC Jr, Watts SD, Arnaud CD, Mason TM, Crans G, Akers R, Draper MW.

Menopause. 2003 Jul-Aug;10(4):337-44.PMID: 12851517 [PubMed - indexed for MEDLINE]Related articles

Raloxifene: a review of its use in postmenopausal osteoporosis.

Clemett D, Spencer CM.

Drugs. 2000 Aug;60(2):379-411. Review.PMID: 10983739 [PubMed - indexed for MEDLINE]Related articles

Clinical efficacy of raloxifene in postmenopausal women.

Agnusdei D.

Eur J Obstet Gynecol Reprod Biol. 1999 Jul;85(1):43-6. Review.PMID: 10428320 [PubMed - indexed for MEDLINE]Related articles

Individualizing therapy to prevent long-term consequences of estrogen deficiency in postmenopausal women.

Col NF, Pauker SG, Goldberg RJ, Eckman MH, Orr RK, Ross EM, Wong JB.

Arch Intern Med. 1999 Jul 12;159(13):1458-66.PMID: 10399897 [PubMed - indexed for MEDLINE]Related articlesFree article

Benefit-risk assessment of raloxifene in postmenopausal osteoporosis.

Cranney A, Adachi JD.

Drug Saf. 2005;28(8):721-30. Review.PMID: 16048357 [PubMed - indexed for MEDLINE]Related articles

Role of raloxifene in breast cancer prevention in postmenopausal women: clinical evidence and potential mechanisms of action.

Sporn MB, Dowsett SA, Mershon J, Bryant HU.

Clin Ther. 2004 Jun;26(6):830-40. Review.PMID: 15262454 [PubMed - indexed for MEDLINE]Related articles

Selective estrogen receptor modulators: an alternative to hormone replacement therapy.

Bryant HU, Dere WH.

Proc Soc Exp Biol Med. 1998 Jan;217(1):45-52. Review.PMID: 9421206 [PubMed - indexed for MEDLINE]Related articles

[Which is the better choice, estrogen or SERMs in postmenopausal women?]

Shintani M.

Clin Calcium. 2004 Oct;14(10):105-10. Review. Japanese. PMID: 15577140 [PubMed - indexed for MEDLINE]Related articles

A controlled trial of raloxifene (LY139481) HCl: impact on bone turnover and serum lipid profile in healthy postmenopausal women.

Draper MW, Flowers DE, Huster WJ, Neild JA, Harper KD, Arnaud C.

J Bone Miner Res. 1996 Jun;11(6):835-42.PMID: 8725181 [PubMed - indexed for MEDLINE]Related articles

Effects of raloxifene on bone metabolism and serum lipids in postmenopausal women on chronic hemodialysis.

Hernández E, Valera R, Alonzo E, Bajares-Lilue M, Carlini R, Capriles F, Martinis R, Bellorin-Font E, Weisinger JR.

Kidney Int. 2003 Jun;63(6):2269-74.PMID: 12753317 [PubMed - indexed for MEDLINE]Related articles

Raloxifene.

Balfour JA, Goa KL.

Drugs Aging. 1998 Apr;12(4):335-41; discussion 342. Review.PMID: 9571395 [PubMed - indexed for MEDLINE]Related articles

The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation.

Cummings SR, Eckert S, Krueger KA, Grady D, Powles TJ, Cauley JA, Norton L, Nickelsen T, Bjarnason NH, Morrow M, Lippman ME, Black D, Glusman JE, Costa A, Jordan VC.

JAMA. 1999 Jun 16;281(23):2189-97. Erratum in: JAMA 1999 Dec 8;282(22):2124. PMID: 10376571 [PubMed - indexed for MEDLINE]Related articlesFree article

Time-dependent changes in biochemical bone markers and serum cholesterol in ovariectomized rats: effects of raloxifene HCl, tamoxifen, estrogen, and alendronate.

Frolik CA, Bryant HU, Black EC, Magee DE, Chandrasekhar S.

Bone. 1996 Jun;18(6):621-7.PMID: 8806005 [PubMed - indexed for MEDLINE]Related articles

[Hormone replacement and selective estrogen receptor modulators (SERMS) in the prevention and treatment of postmenopausal osteoporosis]

Pfeilschifter J.

Orthopade. 2001 Jul;30(7):462-72. Review. German. PMID: 11515185 [PubMed - indexed for MEDLINE]Related articles

Treatment of established postmenopausal osteoporosis with raloxifene: a randomized trial.

Lufkin EG, Whitaker MD, Nickelsen T, Argueta R, Caplan RH, Knickerbocker RK, Riggs BL.

J Bone Miner Res. 1998 Nov;13(11):1747-54.PMID: 9797484 [PubMed - indexed for MEDLINE]Related articles

Characterization of hot flashes reported by healthy postmenopausal women receiving raloxifene or placebo during osteoporosis prevention trials.

Cohen FJ, Lu Y.

Maturitas. 2000 Jan 15;34(1):65-73.PMID: 10687884 [PubMed - indexed for MEDLINE]Related articles